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Abstract
Purpose Bariatric surgery is associated with deficiencies of vitamins and minerals, and patients are routinely advised supple-
ments postoperatively. We studied prevalence of vitamin B12, folate and iron deficiencies and anaemia before and after bariatric
surgery over 4 years of follow-up.
Materials and Methods We performed a retrospective cohort analysis of 353 people with obesity, including 257
(72.8%) women, who underwent gastric bypass (252, 71.4%) or sleeve gastrectomy (101, 28.6%) at our National
Health Service bariatric centre in Northwest England.
Results At baseline, mean (standard error) age was 46.0 (0.6) years, body mass index 53.1 (0.4) kg/m2, serum vitamin B12 400.2
(16.4) pg/L, folate 7.7 (0.2) μg/L, iron 12.0 (0.3) μmol/L, ferritin 118.3 (8.4) μg/L and haemoglobin 137.9 (0.8) g/L. Frequency
of low vitamin B12 levels reduced from 7.5% preoperatively to 2.3% at 48 months (P < 0.038). Mean folate levels increased from
baseline to 48 months by 5.3 μg/L (P < 0.001) but frequency of low folate levels increased from 4.7% preoperatively to 10.3%
(P < 0.048). Ferritin levels increased from baseline to 48 months by 51.3 μg/L (P < 0.009). Frequency of low ferritin levels was
greater in women (39.1%) than in men (8.9%) at baseline (P < 0.001) and throughout the study period. Haemoglobin was low in
4.6% of all patients at baseline with no significant change over the study period.
Conclusion There were notable rates of haematinic insufficiencies in bariatric surgical candidates preoperatively. Our study lends
further support to regular supplementation with vitamin B12, folic acid, and iron in people undergoing bariatric surgery.
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Introduction
Obesity management includes lifestyle, dietary and be-
havioural interventions with or without weight loss
pharmacotherapy. Bariatric surgery, however, is the
most effective option for achieving substantial, sustained
weight loss and improving survival [1, 2]. Globally,
gastric bypass (GB) and sleeve gastrectomy (SG) are
the two most common types of bariatric surgery [3].
Each limits nutrient absorption by either reducing the
stomach volume, as with SG, or a combination of re-
striction of the gastric capacity and reduction of func-
tional small bowel for nutrient absorption, as with GB.
Whilst bariatric surgical procedures are generally safe
with low mortality rates and excellent efficacy in weight
reduction as well as resolution or improvement of co-
morbidities such as type 2 diabetes [1, 2, 4–8], both GB
and SG are frequently associated with micronutrient de-
ficiencies as a consequence of reduced nutrient intake
and absorption [9]. Deficiencies commonly include vita-
min B12 (cobalamin), folate and iron [10].
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Vitamin B12
Cobalamin is an essential co-enzyme in several important
enzyme-catalysed reactions that are involved in synthesis of
DNA, myelin and fatty acids [11]. The reference nutrient in-
take (RNI) for vitamin B12 is 1.5 μg per day for adults [12].
Dietary sources include meat, fish, eggs and dairy foods and
some fortified breakfast cereals. Deficiency can manifest as
glossitis; haematological disorders such as megaloblastic
anaemia, leukopenia, pancytopenia, thrombocytopenia and
thrombocytosis; and neuropsychiatric disorders such as pe-
ripheral neuropathy, demyelination of dorsal columns and
corticospinal tract; cognitive impairment including dementia-
like symptoms and acute psychosis; gait abnormalities, irrita-
bility, and loss of proprioception and vibratory sense; and
olfactory impairment [13]. Vitamin B12 deficiency has been
reported to affect 6% of men and women (aged 19–64 years)
in the UK [14]. Intrinsic factor and/or gastric acid secretion are
essential for the absorption of dietary vitamin B12 in the ileum;
therefore, in altered physiological or pathological states in
which these factors are affected, there is a higher prevalence
of vitamin B12 deficiency [15]. People who have undergone
gastric bypass, sleeve gastrectomy and duodenal switch are
therefore at risk of cobalamin deficiency due to surgically
distorted anatomy and physiological function. This often
manifests after a delay of 2 years post-surgery due to
hepatic storage of vitamin B12 [16]. It is therefore rec-
ommended that patients receive 3-monthly intramuscular
hydroxocobalamin injections following bariatric surgery
to replenish dwindling stores [17].
Folate
The RNI for folate is 200 μg per day for adults; women re-
quire an extra 100 μg during pregnancy [12]. Women who are
planning pregnancy are advised 400 μg of folic acid daily
until the 12th week of pregnancy [18]; a higher dose of
5 mg per day is recommended for women who have had
bariatric surgery [17, 19]. Dietary sources of folate include
green leafy vegetables and fortified cereals and supplements.
Folate deficiency after bariatric surgery is less common as it is
absorbed throughout the small bowel but daily supplementa-
tion is still advised due to limited body stores [17, 20].
Iron
The RNI for iron is 8.7 mg per day for men and women over
50 years of age and 14.8 mg for women under 50 [12]. Dietary
haem iron from animal sources has the most bioavailability;
sources include red meat, liver and poultry. Non-haem iron,
which is less well absorbed, can be found in vegetables, nuts
and eggs [21]. In the UK, bread and flour (other than whole-
meal flour) and many breakfast cereals are fortified with iron.
Iron absorption can be inhibited or enhanced by certain dietary
compounds [22]. Phytates in plant-based foods and polyphe-
nols from tea, coffee, legumes, cereals, fruit and vegetables
can inhibit absorption of non-haem iron. Oral calcium inhibits
absorption of both haem and non-haem iron. Oral vitamin C
may enhance absorption of non-haem iron by reducing ferric
ions to more readily absorbable ferrous forms [23].
Iron deficiency resulting in microcytic anaemia is one of
the most common nutritional problems following bariatric
surgery [20]. This probably relates to the combination of re-
duced oral intake and reduced gastric acid secretion required
for iron absorption, along with bypassing of segments of the
small bowel where iron absorption occurs, as in the case of
GB [24, 25]. It has also been noted that patients with obesity
are more likely to have pre-existing iron deficiency [26].
Consequently, current national guidelines and local
guidelines at our centre recommend 45–60 mg of oral
elemental iron per day in addition to dietary intake post-
bariatric surgery [17, 27].
Previous studies have mostly reported short-term results.
We therefore studied longitudinal data on vitamin B12, folate,
iron, ferritin and haemoglobin levels in a sizable baseline co-
hort followed up over 4 years after bariatric surgery. Whilst
patients with obesity are routinely recommended supplements
of iron, multivitamins and hydroxocobalamin following bar-
iatric surgery by learned society guidelines [17, 27], there is
limited knowledge of the efficacy of the routinely recom-
mended standard supplements in treating and preventing in-
sufficiencies after bariatric surgery in the longer term.
Aims
We studied levels of haematinics and haemoglobin in patients
undergoing bariatric surgery over 4 years of follow-up at a
single centre to identify prevalence of deficiencies pre- and
postoperatively.
Methods
We performed an observational cohort analysis of patients
who underwent bariatric surgery between August 2010 and
October 2012 at our National Health Service (NHS) university
teaching hospital in Greater Manchester, UK. Patients were
identified from our bariatric surgery database, and clinical
information was collected from electronic patient records.
We evaluated all patients who underwent GB (252, 71.4%)
or SG (101, 28.6%); 15 patients who underwent other primary
bariatric surgical procedures (14 gastr ic band, 1
biliopancreatic diversion/duodenal switch) were excluded.
All 252 GB procedures were performed as laparoscopic
Roux-en-Y gastric bypass involving the fashioning of a short
5 cm vertical gastric pouch based on the lesser curvature of the
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stomach and constructed over a 40-French orogastric tube
using staplers. An antecolic antegastric Roux-en-Y
gastrojejunostomy was fashioned with the bilioenteric limb
measuring 100 cm and the alimentary limb measuring 100–
150 cm depending on the patient’s body mass index (BMI). A
side-to-side jejunojejunostomy was fashioned using
intracorporeal suturing technique, and an end-to-side
gastrojejunostomy was constructed using intracorporeally su-
tured technique over a 40-French orogastric tube. The
jejunojejunal and Petersen’s mesenteric defects were
rout ine ly closed us ing nonabsorbable sutures .
Laparoscopic SG involved the construction of a vertical
gastric sleeve over a 40-French orogastric tube starting
4–6 cm from the pylorus and ending approximately
1 cm lateral to the angle of His using staplers.
All patients were prescribed oral complete micronutrient/
multivitamin supplement (Forceval®) including folic acid
400 μg, oral iron (ferrous sulfate 400 mg) and oral combined
calcium and vitamin D (elemental calcium 1200 mg and cho-
lecalciferol 800 units) daily, and hydroxocobalamin 1 mg in-
tramuscular injection every 3 months. Scheduled postopera-
tive follow-up appointments were at 6 weeks, 4 months,
12 months and annually thereafter for clinical assessment
and blood tests. The data assembled included height, weight
and BMI, and serum levels of vitamin B12, folate, iron, ferri-
tin, haemoglobin and mean corpuscular volume (MCV) at
baseline and 4, 12, 24, 36 and 48 months postoperatively.
Low levels of vitamin B12 (< 211.0 ng/L), folate (<
4.0 μg/L), iron (< 9 μmol/L in women and < 11 μmol/L in
men), haemoglobin (< 115 g/L in women and < 130 g/L in
men) and MCV (< 80 fL) were defined as per their respective
laboratory recommended reference ranges [28]. Ferritin levels
were defined as deficient (< 15 μg/L) or insufficient (<
50 μg/L) [29]. Statistical analysis included descriptive statis-
tics, parametric tests (or non-parametric tests for non-
normative data as appropriate) and contingency tables using
Fisher’s exact test. P < 0.05 was deemed to be statisti-
cally significant, and 95% confidence intervals (95%
CI) were reported where appropriate. Data were
analysed using IBM SPSS 25.0 (Armonk, NY) and
GraphPad Prism 7.0 (San Diego, CA).
Results
We studied longitudinal data on haematinics in 353 patients
comprised of 257 (72.8%) women. The mean (standard error
of the mean) age was 46.0 (0.56) years and BMI was 53.1
(0.38) kg/m2 at baseline; 129 (36.5%) patients had type 2 dia-
betes; 252 patients (71.4%) had undergone GB and 101
(28.6%) SG; women had significantly lower ferritin, iron and
haemoglobin levels compared to men at baseline (Table 1).
Weight Loss
There was significant weight loss after bariatric surgery; over-
all mean difference (95% CI) in BMI from baseline to
48 months was a reduction of 15.2 (14.1 to 16.4) kg/m2
(P < 0.001). BMI reduction was not significantly different be-
tween men and women throughout the period of study but
was greater for GB compared to SG with a mean difference
(95% CI) of 3.35 (1.63 to 5.07) kg/m2 (P < 0.001) at
12 months and after (Fig. 1). BMI reduction was not signifi-
cantly different between younger (preoperative age < 50 years)
and older patients but greater in those with lower preoperative












Age (years) 46.01 (0.56) 45.91 (1.02) 46.04 (0.67) ns 45.27 (0.65) 47.84 (1.10) 0.046
BMI (kg/m2) 53.07 (0.38) 53.34 (0.76) 52.97 (0.45) ns 53.10 (0.42) 52.98 (0.84) ns
Vitamin B12 (pg/L) 400.22 (16.43) 387.00 (17.48) 405.15 (21.62) ns 391.07 (17.72) 424.74 (37.54) ns
Folate (μg/L) 7.68 (0.23) 7.88 (0.40) 7.60 (0.27) ns 7.35 (0.25) 8.54 (0.47) 0.027
Iron (μmol/L) 11.96 (0.28) 13.57 (0.64) 11.38 (0.29) < 0.003 12.04 (0.34) 11.74 (0.50) ns
Ferritin (μg/L) 118.31 (8.43) 175.49 (19.97) 98.96 (8.45) < 0.001 114.04 (10.63) 127.61 (13.56) ns
Haemoglobin (g/L) 137.90 (0.75) 149.10 (1.34) 133.68 (0.74) < 0.001 138.22 (0.83) 137.12 (1.58) ns
MCV (fL) 87.21 (0.27) 87.44 (0.47) 87.13 (0.33) ns 87.41 (0.32) 86.73 (0.51) ns
Values reported as mean (standard error of the mean)
*Men vs. women
†Gastric bypass vs. sleeve gastrectomy
Independent samples t test, equal variances not assumed
ns non-significant. BMI body mass index, MCV mean corpuscular volume
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BMI (< 50 kg/m2) throughout with a mean difference
(95% CI) of 8.17 (5.99 to 10.34) kg/m2 (P < 0.001) at
48 months. Percent total weight loss (%TWL) was greater
for GB than SG at 4 months and after with greatest mean
difference (95% CI) of 8.50 (5.59 to 11.41)% at 24
months (P < 0.001), but there was no difference by sex, age
or preoperative BMI.
Vitamin B12
Low serum vitamin B12 levels (< 211 ng/L) were seen in 7.5%
of patients overall at baseline compared to 2.3% at 48 months
(P < 0.038) (Table 2). There were no statistically significant
differences in rates of deficiency grouped by sex or type of
surgery (Fig. 2). Of 129 people with type 2 diabetes, 104
(80.6%) were taking metformin prior to surgery; median (in-
terquartile range) vitamin B12 level in those taking metformin
was 349.5 (277.3 to 460.0) ng/L whilst in those not taking
metformin was 429.0 (315.0 to 571.0) ng/L (P = 0.54).
Serum vitamin B12 levels increased after bariatric surgery
(Fig. 2). Mean difference (95% CI) in vitamin B12 levels from
baseline to 48 months was an increase of 195.1 (84.9 to
305.2) pg/L (P < 0.001). Women had higher mean vitamin
B12 levels compared to men at 24 months (486.9 vs.
436.0 ng/L, P < 0.03) and 48 months (482.4 vs. 306.8 ng/L,
P < 0.001). SG patients had a higher mean vitamin B12 level
compared to GB at 12 months (807.5 vs. 625.3 ng/L,
P < 0.013), but not at other timepoints.
Fig. 1 Weight loss outcomes during 4 years of follow-up after bariatric
surgery: a body mass index (BMI) categorized by sex or type of surgery,
b BMI categorized by preoperative BMI (< 50 kg/m2 or ≥ 50 kg/m2) or
age (< 50 years or ≥ 50 years), c percent total weight loss (%TWL) cate-
gorized by sex or type of surgery, and d %TWL categorized by
preoperative BMI or age. Point values (± error bars) depict means (±
standard errors of the means). At each timepoint, fractions depict number
of participants contributing data (numerator) over total number of eligible
participants (denominator)
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Folate
Low serum folate levels were seen in 4.7% patients overall at
baseline compared to 10.3% at 48 months (P < 0.048) (Table 2).
Rates of folate deficiency increased in SG patients from 2.9% at
baseline to 17.5% at 48 months (P < 0.012), but there was no
statistically significant change in GB patients or men or women
(Fig. 2). The frequency of folate deficiency increased in younger
patients (preoperative age < 50 years) from 5.7% at baseline to
16.1% at 48 months (P < 0.029) and in patients with higher
preoperative BMI (≥ 50 kg/m2) from 5.7 to 13.9% (P < 0.046).
Serum folate levels increased after bariatric surgery (Fig. 2).
Mean difference (95% CI) in serum folate levels from baseline
to 48 months was an increase of 5.3 (3.8 to 6.8) μg/L (P< 0.001).
There was no significant difference in mean levels between men
and women at any timepoint. SG patients had higher mean serum
folate levels compared to GB at baseline (8.54 vs. 7.35 μg/L,
P< 0.03) (Table 1), but not at postoperative follow-up timepoints.
Iron and Ferritin
Low serum iron levels were seen in 29.8% of all patients with a
higher rate in men (40.0%) than women (26.1%; P< 0.041) at
baseline (Fig. 3), even when comparing to men and women <
50 years (43.2% vs. 29.2%; ns, not significant). At 48 months,
the rate of low serum iron reduced to 17.2% in men (P < 0.035)
but there was no significant change in women at 31.5% overall
(ns) and women < 50 years at 37.8% (ns). There was no signif-
icant difference in rates of low serum iron between procedures.
Serum iron levels increased after bariatric surgery, peaking at
12 months with a slow decline in levels thereafter (Fig. 3).
Mean difference (95% CI) in serum iron levels from baseline
to 48 months was an increase of 1.99 (0.54 to 3.45) μmol/L
(P < 0.008). Iron levels were significantly higher in men com-
pared to women at baseline (13.57 vs. 11.38 μmol/L; P < 0.003)
and 48 months (16.62 vs. 12.62 μmol/L; P < 0.006). There was
no significant difference between procedures at baseline, but iron
levels were higher in GB patients compared to SG patients at
24 months (15.33 vs. 13.11 μmol/L; P < 0.013) and 36 months
(14.68 vs. 12.54μmol/L;P < 0.036). Olderwomen (preoperative
age ≥ 50 years) had higher iron levels compared to younger
women at 4 months (14.91 vs. 12.98 μmol/L; P < 0.003) and
24 months (16.01 vs. 12.91 μmol/L; P < 0.002). Those women
who had iron deficiency at baseline had a mean serum iron of
7.01 μmol/L, which increased modestly to 9.61 μmol/L at
48 months (Table 3).
Table 2 Proportion of patients
with deficiency in haematinics
and haemoglobin and comparison
with previous studies
Baseline 12 months 24 months 36 months 48 months
All patients
Vitamin B12 (%) 7.5 4.4 3.5 1.3 2.3
Folate (%) 4.7 4.9 1.6 4.5 10.3
Serum iron (%) 29.8 15.6 19.3 19.6 27.3
Ferritin (%) 1.1 1.3 4.3 7.1 9.3
Haemoglobin (%) 2.6 4.3 4.7 6.0 7.4
Bypass
Vitamin B12 (%) 8.1 (2.3
a) 5.5 (6.5a) 4.8 (5.4a) 1.7 (7.2a) 3.3
Folate (%) 5.4 (2.2a) 4.5 (1.6a) 0.7 (1.8a) 3.4 (0.7a) 7.0
Iron (%) 28.7 (14.7b–15.3a) 17.0 (10.5a) 17.5 (9.8a) 18.6 (10.2a) 24.7
Ferritin (%) 1.6 1.2 4.4 7.7 10.3
Haemoglobin (%) 1.6 (12.2a) 3.2 (20.9a) 5.1 (25.9a) 5.7 (23.1a) 6.9
Sleeve
Vitamin B12 (%) 5.8 (5.9
d–9.3c) 1.5 (7.8c–17.2d) 0.0 (1.0e) 0.0 (18.0f) 0.00
Folate (%) 2.9 (0.0c–5.5d) 5.9 (13.7c–13.8d) 4.00 8.1 (22.0f) 17.50
Serum iron (%) 32.9 (36.6b) 11.9 24.0 22.9 35.1
Ferritin (%) 0.00 1.47 4.08 0.00 7.14
Haemoglobin (%) 4.9 7.3 3.5 7.0 8.7
Values (comparison with previous studies) reported as percentages (%)
aWeng et al. [20]
b Enani et al. [35]
c Antoniewicz et al. [38]
d Damms-Machado et al. [32]
e Javanainen et al. [40]
f Gehrer et al. [37]
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Serum ferritin levels increased after bariatric surgery
(Fig. 3). Mean difference (95% CI) in serum ferritin
level from baseline to 48 months was an increase of
51.3 (13.4 to 89.2) μg/L (P < 0.009). Ferritin levels
were significantly higher in men than in women at base-
line (175.5 vs. 99.0 μg/L; P < 0.001), but there was no
significant difference between procedures. Ferritin levels
were low or insufficient in 2.8% and 28.7% of all pa-
tients, respectively, at baseline (Fig. 3). Rates of ferritin
sufficiency were higher in men than in women at base-
line (91.1% vs. 60.9%; P < 0.001) and throughout the
period of study, but there was no significant difference
between procedures.
Haemoglobin
There was no significant change in mean haemoglobin
levels overall or within groups throughout the study
period (Fig. 4). Men had higher haemoglobin levels
compared to women throughout (P < 0.001), but there
was no significant difference between procedures. Low
haemoglobin was seen in 4.6% of all patients at base-
line with no significant change over the period of study
(Table 2). Rates of anaemia were not significantly dif-
ferent between sexes or procedures. The mean
haemoglobin in those women who were anaemic at
baseline was 103.25 g/L, and this increased to
117.33 g/L by 48 months (Table 3).
There was no significant difference in mean corpus-
cular volume (MCV) overall or within groups or be-
tween groups throughout the study period (Fig. 4).
Low MCV was seen in 7.1% and high MCV in 0.6%
of all patients at baseline, with no significant change or
difference between groups throughout the study period.
Preoperative age and BMI had no significant effect on
the frequency of anaemia.
Fig. 2 Haematinic levels during 4 years of follow-up after bariatric sur-
gery categorized by sex and type of surgery: a vitamin B12 levels, b
proportions of patients with sufficient (black) or low (< 211 ng/L; grey)
vitamin B12 levels, c serum folate levels, and d proportions of patients
with sufficient (black) or low (< 4.0 μg/L; grey) serum folate levels. In
line graphs, points (± error bars) represent means (± standard errors of the
means). At each timepoint, fractions depict number of participants con-
tributing data (numerator) over total number of eligible participants (de-
nominator). In column charts, the first column at each timepoint repre-
sents all patients, second men, third women, fourth gastric bypass, and
fifth sleeve gastrectomy
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Discussion
We studied deficiencies of haematinics, namely vitamin B12,
folate and iron, before and after bariatric surgery over 4 years
of follow-up. Very few patients in our cohort had anaemia
preoperatively, lower than in the general population or other
studies describing 7–22% [20, 30]. However, we report defi-
ciencies of iron in three-tenths, vitamin B12 in nearly one-tenth
and folate in one-twentieth of patients preoperatively, rates
that are higher than in the general population [16, 30, 31],
and corroborate previous findings of a prevalence of iron de-
ficiency of 30–40% [26], as well as vitamin B12 and folate
deficiencies prior to surgery [32, 33].
A higher rate of preoperative low serum iron levels in men
was observed in our study, in contrast to previous work which
has demonstrated male gender to be protective against iron
deficiency [26].We report an early improvement in iron levels
in both men and women, irrespective of type of surgery, but
with a similar proportion of patients with low iron levels at
48 months. Women under 50 years had a lower mean serum
iron level than those 50 and over, corroborating previous find-
ings of a higher frequency of iron deficiency in menstruating
women [34]. There was a significant improvement in iron
deficiency inmen over this time; however, tendencies towards
abrogation of iron deficiency in women and according to each
type of surgery remained statistically non-significant. A recent
meta-analysis of twenty studies between 2000 and 2015 re-
ported similar absolute rates of iron deficiency when compar-
ing procedures, with a frequency of 22.5% post-GB and
12.4% post-SG, but with an increased risk of iron deficiency
after GB but not SG, from a baseline of 14.7% and 36.6%,
respectively [35]. This worsening of iron status after GB has
been noted elsewhere [20] and is likely due to bypassing of the
stomach and duodenum, precluding efficient iron absorption
[24]. Iron deficiency may also reflect loss of iron in those
women who menstruate, in addition to the population in
Fig. 3 Haematinic levels during 4 years of follow-up after bariatric sur-
gery categorized by sex and type of surgery: a serum iron levels, b
proportions of patients with sufficient (black) or low serum iron levels
(< 9 μmol/L in women, < 11 μmol/L in men; grey), c serum ferritin
levels, and d proportions of patients with sufficient (black) or
insufficient/low (< 50 μg/L; grey) serum ferritin levels. In line graphs,
points (± error bars) represent means (± standard errors of the means). At
each timepoint, fractions depict number of participants contributing data
(numerator) over total number of eligible participants (denominator). In
column charts, first column at each timepoint represents all patients, sec-
ondmen, third women, fourth gastric bypass, and fifth sleeve gastrectomy
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whom menstruation resumes after bariatric surgery fol-
lowing correction of obesity-related anovulation and in-
sulin resistance [24].
Although mean ferritin levels increased over the course of
follow-up in our study, probably related to the supplementa-
tion regime and initial good adherence, a higher proportion of
patients had insufficiency by 48 months despite an initial rise
at 4 and 12 months. This has been noted elsewhere and is
thought to correlate with a heightening of the inflammatory
state associated with the greater degree of weight loss over the
first 6 months postoperatively [36]. In this study by de Cleva
et al. [36], iron deficiency anaemia replaced anaemia of chron-
ic disease as the predominant cause of anaemia after GB,
attributed to postoperative food aversions, malabsorp-
tion, menstruation, and reduction in the obesity-related
proinflammatory state.
Table 3 Trend of haematinic and
haemoglobin levels over 4 years
of follow-up. Patients were
grouped by baseline levels of
deficiencies of vitamin B12,
folate, iron, ferritin and
haemoglobin
Baseline 4 months 12 months 24 months 36 months 48 months
Vitamin B12 (pg/L)
All, not deficient (n = 235) 417.98 621.82 671.29 716.60 676.03 646.47
All, deficient (n = 19) 180.47 529.93 622.92 763.70 579.90 473.00
Men, not deficient (n = 62) 409.42 580.27 598.38 541.57 530.13 395.60
Men, deficient (n = 7) 188.43 705.20 751.00 819.25 669.20 440.00
Women, not deficient
(n = 173)
421.05 636.47 695.01 780.41 718.73 718.14
Women, deficient (n = 12) 175.83 442.30 566.00 726.67 490.60 522.50
Folate (μg/L)
All, not deficient (n = 242) 7.89 10.71 11.89 12.45 13.30 12.70
All, deficient (n = 12) 3.36 10.33 11.34 13.78 13.44 10.20
Men, not deficient (n = 65) 8.06 10.53 11.05 11.61 11.50 10.79
Men, deficient (n = 3) 3.80 14.48 14.60 19.80 24.10 16.10
Women, not deficient
(n = 177)
7.83 10.77 12.16 12.75 13.90 13.35
Women, deficient (n = 9) 3.21 08.77 10.88 11.77 10.78 4.30*
Iron (μmol/L)
All, not deficient (n = 175) 13.71 15.07 15.81 15.03 15.06 14.67
All, deficient (n = 74) 7.80 11.54 12.75 12.56 11.49 11.46
Men, not deficient (n = 39) 16.44 17.50 19.44 16.19 19.63 19.13
Men, deficient (n = 26) 9.27 12.57 16.77 14.56 14.88 14.62
Women, not deficient
(n = 136)
12.93 14.40 14.88 14.71 13.93 13.60
Women, deficient (n = 48) 7.01 10.96 10.68 11.37 10.10 9.61
Ferritin (μg/L)
All, not deficient (n = 227) 119.52 156.92 178.33 184.93 194.24 178.20
All, deficient (n = 2) 11.50 44.00 31.00 8.00 8.00 5.00
Men, not deficient (n = 95) 179.14 189.47 191.03 205.64 215.35 175.24
Men, deficient (n = 1) 15.00 46.00 31.00 8.00 8.00 6.00
Women, not deficient
(n = 132)
99.65 132.65 169.86 170.34 182.03 179.81
Women, deficient (n = 1) 8.00 42.00 – – 8.00 4.00
Haemoglobin (g/L)
All, not low (n = 342) 138.77 140.10 136.71 136.53 136.31 134.33
All, low (n = 9) 104.89 117.86 119.17 123.50 117.33 120.00
Men, not low (n = 95) 149.43 148.54 146.06 147.75 149.03 145.82
Men, low (n = 1) 118.00 129.00 129.00 141.00 132.00 128.00
Women, not low (n = 247) 134.67 136.84 133.46 132.45 132.18 130.74
Women, low (n = 8) 103.25 116.00 117.20 120.00 114.40 117.33
Values reported as mean
*Data available for one patient only
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Obesity is not known as a risk factor for vitamin B12 deficien-
cy per se, but may occur in the context of use of metformin and
proton pump inhibitors, and poor nutrient intake [16].Metformin
use in our cohort was not associated with vitamin B12 deficiency.
Vitamin B12 deficiency has been reported to be more frequent
after GB compared to SG [37–40], probably as a consequence of
reduced gastric acid and intrinsic factor production [20], although
no significant difference was observed in our study. A meta-
analysis of nutrient deficiencies after bariatric surgery found a
prevalence of cobalamin deficiency increasing from 2.3% at
baseline to 7.2% at 36 months post-GB despite supplementation
[20]. This contrasts our findings of a decrease in prevalence of
cobalamin deficiency; however, this is unsurprising as previous
studies predominantly involved the use of oral multivitamins to
provide vitaminB12with only half supplementingwith intramus-
cular cobalamin. Other work has shown that either intramuscular
or high-dose oral cobalamin supplementation is required to pre-
vent deficiency [31].
An improvement in the proportion of patients with folate
deficiency after GB has been noted [20], which may be attrib-
uted to supplementation with multivitamins postoperatively as
well as fortification of a host of foodstuffs with folic acid [31].
There is increased risk of folate deficiency post-GB related to
decreased gastric acid secretion and reduced absorption due to
bypassing of the upper segment of the small intestine [39].We
observed an increased frequency of folate deficiency after SG,
but not GB, which has been noted elsewhere [37, 38], al-
though the cause of this remains to be elucidated. Higher
preoperative BMI was associated with folate deficiency.
This corroborates previous findings [41], and may be related
to a high-calorie diet deficient in micronutrients [31].
Weng et al. evaluated nine studies from 2009 to 2014 and
found an increase from 12% of patients with anaemia prior to
GB to 23% at 36 months, despite supplementation with mul-
tivitamins in most reports [20]. We found lower prevalence of
anaemia, probably due to our regimen of supplementation
Fig. 4 Haematinic levels during 4 years of follow-up after bariatric sur-
gery categorized by sex and type of surgery: a haemoglobin (Hb) levels, b
proportions of patients with sufficient (black) or low (< 115 g/L in wom-
en, < 130 g/L in men; grey) haemoglobin levels, c mean corpuscular
volume (MCV) levels, and d proportions of patients with satisfactory
(black) or out-of-range (< 80 or > 100 fL; grey) MCV levels. In line
graphs, points (± error bars) represent means (± standard errors of the
means). At each timepoint, fractions depict number of participants con-
tributing data (numerator) over total number of eligible participants (de-
nominator). In column charts, first column at each timepoint represents all
patients, second men, third women, fourth gastric bypass and fifth sleeve
gastrectomy
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with iron tablets containing higher doses of iron. Data regard-
ing the relative risk of anaemia after SG compared to GB
remains conflicting. A study of 306,298 patients described a
two-fold higher risk of anaemia after GB compared to SG
[42], with similar findings reported recently [35]. In contrast,
a meta-analysis by Kwon et al. in 2014 did not demonstrate a
significant difference in the rates of anaemia between the two
types of surgery [43].
A recent study has reported higher rates of anaemia and
iron and vitamin B12 deficiencies at two and 3 years postop-
eratively after gastric bypass [44]. Two other studies have
reported differing findings regarding the effect of surgery on
haematinic status. Misra et al. [45] described no significant
difference in rates of anaemia or deficiencies in ferritin, vita-
min B12 or folate between GB and SG at 3 years’ follow-up, a
result echoed in our study. Ledoux et al. [46] similarly report-
ed no effect of type of procedure on vitamin B12 deficiency or
anaemia, although rates of anaemia increased more substan-
tially after GB; there was a higher frequency of folate defi-
ciency after SG compared to GB.
Clearly there is some heterogeneity, and further work
is required to delineate the risk of anaemia attributed to
each procedure. Despite an increase in iron and folate
deficiency throughout 48 months of follow-up, this was
not correlated with a concomitant rise in the frequency
of anaemia. Low serum iron levels became more fre-
quent beyond 12 months after surgery. This suggests
reduced adherence to recommended supplementation.
Haematinic deficiencies remain a risk for development
of anaemia, and longer follow-up is required to deter-
mine whether these deficiencies would ultimately prog-
ress to anaemia.
In an effort to improve the frequency of haematinic defi-
ciencies and consequent anaemia post-bariatric surgery, a
multidisciplinary team approach is crucial to encourage pa-
tient engagement to continue taking supplements postopera-
tively, with a particular focus on women of childbearing age
[19]. Our practice includes multidisciplinary, patient-focused
approach with peer-group support and the improvements in
haematinic levels in our study provide evidence of high levels
of medication adherence by patients. Additionally, given the
high frequency of iron deficiency preoperatively, there may be
a case for consideration of providing supplementation even
prior to surgery. Obesity itself is associated with reduced se-
rum iron levels, firstly due to poor iron intake and secondly
because of hepcidin upregulation as part of the inflammatory
milieu, thereby resulting in functional deficiency [47]. Thus,
supplementation may not be enough to prevent iron de-
ficiency in either non-surgical candidates or those post-
operatively but remains the main treatment option to
optimize iron status at present. Parenteral iron is expen-
sive and more difficult to administer, but is effective in
cases of refractory iron deficiency anaemia [36].
Studies support the use of a pharmaceutical-grade multi-
vitamin, the use of which resulted in reduction in rates of
haematinic deficiencies and anaemia after GB [48, 49]. The
multivitamin used in the study by Homan et al. included
350 μg of vitamin B12 [48], which may be sufficient to
overcome deficiency as 1–5% of vitamin B12 is absorbed
by an intrinsic factor-independent mechanism [16].
However, other studies demonstrated higher doses of oral
hydroxocobalamin are required, with 1000 μg per day prov-
ing optimal to manage vitamin B12 deficiency after GB [50].
Furthermore, in a study comparing oral and intramuscular
cobalamin, there was no significant difference in improve-
ment in vitamin B12 levels, suggesting that high-dose oral
vitamin B12 (1000 μg per day) is sufficient to overcome
deficiency [51]. Whether oral vitamin B12 can prevent defi-
ciency in a real-world setting remains to be seen.
Limitations of this study include its retrospective design
(although data was accumulated prospectively) and data at-
trition due to patients lost to follow-up. It was beyond the
scope of this pragmatic, real-world, retrospective observa-
tional study to accurately confirm adherence to recommend-
ed post-surgical supplementations. Previous studies have
reported adherence to vitamin supplementation post-
bariatric surgery may be as low as 30%, and risk factors
for poor adherence include male gender, full-time work
and attachment anxiety [52]. Poor adherence with iron ther-
apy is well-documented, resulting from various factors in-
cluding frequent side effects, unavailability of supplements,
lack of education and/or support by healthcare profes-
sionals, and low demand for treatment due to lack of symp-
toms of anaemia [53]. In cases where iron deficiency per-
sists despite good adherence, parenteral supplementation is
usually required especially in menstruating and pregnant
women [54]. It was beyond the scope of this work to ascer-
tain menstruation status in women of childbearing age. We
also did not evaluate albumin, copper and zinc levels which
can rarely contribute to anaemia.
In summary, we report a high proportion of haematinic
deficiencies preoperatively, especially in iron. A strong focus
on encouragement of patients to continue taking supplements
post-bariatric surgery is imperative, and there may even be an
argument for consideration of iron supplementation prior to
surgery, especially in pre-menopausal women.
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